Last reviewed · How we verify

Methylphenidate Pill — Competitive Intelligence Brief

Methylphenidate Pill (Methylphenidate Pill) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 2 Small molecule Live · refreshed every 30 min

Target snapshot

Methylphenidate Pill (Methylphenidate Pill) — ANRS, Emerging Infectious Diseases.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Methylphenidate Pill TARGET Methylphenidate Pill ANRS, Emerging Infectious Diseases phase 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methylphenidate Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/methylphenidate-pill. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: